Therapeutic Areas
Ideas
Use chemogenetics to map out neural circuits relevant to disease. Scott Sternson has a new class of ion channels that can be selectively engaged by an FDA-approved synthetic molecule called varenicline. If the ion channels can be expressed in cells of interest, oral doses of varenicline could have therapeutic potential. FierceBiotech
People
- Elma Hawkins - CEO
- David Bleakman - CSO
- Jeffrey Friedman - Rockefeller, Founder
- Scott Sternson - Janelia Farms
- Michael Kaplitt - Weil Cornell
- Sarah Stanley - Mount Sinai
- Jonathan Dordick - Rensselaer Polytechnic Institute
Funding
- Venture Round: $1.5M 2018-03 link
Partners
Updated 2019-09-20.